-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Praxis Precision Medicines, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
- Praxis Precision Medicines, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $12.4M, a 116% increase year-over-year.
- Praxis Precision Medicines, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $38.5M, a 51% increase year-over-year.
- Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $24.9M, a 13.1% decline from 2022.
- Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28.6M, a 26% increase from 2021.
- Praxis Precision Medicines, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $22.7M, a 335% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)